Clinical Trials Browser

Phase 2 × OTHER × satraplatin × Clear all

NCT01289067 2018-02-13

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

Phase 2 Completed

13 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms